The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistance
Author:
Funder
National Cancer Institute
Roswell Park Alliance Foundation
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference145 articles.
1. Distinct receptor tyrosine kinase subsets mediate anti-HER2 drug resistance in breast cancer;Alexander;The Journal of Biological Chemistry,2017
2. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): A randomised, double-blind, placebo-controlled phase 3 trial;Andre;The Lancet Oncology,2014
3. Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation;Anido;The EMBO Journal,2006
4. Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy;Arpino;Journal of the National Cancer Institute,2007
5. p95HER2 and breast cancer;Arribas;Cancer Research,2011
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the functions of five recently characterized lncRNAs in cancer progression;Clinical and Translational Oncology;2024-07-27
2. Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models;Drug Resistance Updates;2024-05
3. CDK7 in breast cancer: mechanisms of action and therapeutic potential;Cell Communication and Signaling;2024-04-11
4. IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 Therapy;Clinical Cancer Research;2024-04-05
5. Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations;Journal of Drug Delivery Science and Technology;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3